What’s Next in Nevada for Cannabis After Trump’s Move to Reclassify It as a Less-Dangerous Drug?
Trump's federal reclassification of marijuana as a less-dangerous drug supports medical research and intensifies Pennsylvania's 2026 legalization debate amid potential $500 million revenue gains.
- On Thursday, President Donald Trump signed an executive order moving marijuana from Schedule I to Schedule III, saying the change does not legalize recreational use.
- The White House said rescheduling corrects delayed recognition of medical use and will vastly improve research on safety and efficacy, aiding medical researchers and the pharmaceutical industry.
- On May 5 the House Health Committee approved a Democrat-driven bill in a party-line vote and the full House approved it two days later, though a Republican-controlled Senate committee later rejected the measure.
- The move immediately intensified public comment and debate in Pennsylvania, where medical use is legal but recreational use is not, while Democratic Gov. Josh Shapiro penciled in more than $500 million in anticipated revenue and lawmakers are not expected to return until early 2026.
- Banking and decriminalization remain separate issues, limiting shifts despite federal reclassification; state-legal cannabis businesses could deduct expenses with the Internal Revenue Service, but criminal penalties tied to weight under the Controlled Substances Act persist.
11 Articles
11 Articles
What’s next in Nevada for cannabis after Trump’s move to reclassify it as a less-dangerous drug?
Under reclassification, state-legal cannabis businesses would be able to deduct expenses with the Internal Revenue Service, “the same as any other company would do,” according to a report.
Trump lied about cannabis rescheduling opposition, GOP senator says (Newsletter: December 22, 2025)
Marijuana banking bill momentum; State legalization gets boost from Trump move; GOP AGs concerned over cannabis rescheduling; FL legalization to court Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possi…
Optimism grows that Trump order on marijuana could improve medical products, shift legalization debate in Pa.
HARRISBURG — There’s no immediate impact in Pennsylvania following President Donald Trump’s executive order to pursue a reclassification of marijuana, but advocates say that in time it could lead to better products at a cheaper cost in the commonwealth’s legal…
President Donald Trump signed an executive order last week directing federal officials to reclassify marijuana as a less dangerous drug — a major shift in federal drug policy that could open new avenues for medical research and ease the tax burden for cannabis companies in Nevada. The change would remove marijuana from its current classification as a Schedule I drug, alongside heroin. Cannabis would then be reclassified as a Schedule III substan…
Coverage Details
Bias Distribution
- 50% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium








